The competing interests section was incomplete. The following sentence should be included: RG wishes to disclose a competing interest in AngioChem Inc., subsequent to his involvement in the present study as Director of BBB Research at Synapse Technologies Inc.
. 2008 Aug 18;3(8):10.1371/annotation/40c256ca-5d98-4ca9-a388-c9dac8f20924. doi: 10.1371/annotation/40c256ca-5d98-4ca9-a388-c9dac8f20924
Correction: A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
Delara Karkan
, Cheryl Pfeifer
, Timothy Z Vitalis
, Gavin Arthur
, Maki Ujiie
, Qingqi Chen
, Sam Tsai
, Gerrasimo Koliatis
, Reinhard Gabathuler
, Wilfred A Jefferies
Delara Karkan
Find articles by Delara Karkan
Cheryl Pfeifer
Find articles by Cheryl Pfeifer
Timothy Z Vitalis
Find articles by Timothy Z Vitalis
Gavin Arthur
Find articles by Gavin Arthur
Maki Ujiie
Find articles by Maki Ujiie
Qingqi Chen
Find articles by Qingqi Chen
Sam Tsai
Find articles by Sam Tsai
Gerrasimo Koliatis
Find articles by Gerrasimo Koliatis
Reinhard Gabathuler
Find articles by Reinhard Gabathuler
Wilfred A Jefferies
Find articles by Wilfred A Jefferies
Collection date 2008.
Public Library of Science.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
PMCID: PMC2645285
This corrects the article "A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier", e2469.
